Copper histidine
In vial of 0.5 g net
TargetMol Chemicals Inc.
Product Overview
Product / Grade Name
Copper histidine
Maker Name
Product Description
Copper histidine inhibited Ctr1-mediated cellular uptake of oxaliplatin in vitro without altering oxaliplatin accumulation of platinum or neurotoxicity in DRG tissues in vivo. Copper histidine is administered orally for the treatment of Menkes disease.
Hazard Classification
UN Number
:IMGD Class
:Packing Group
:
Visual Overview
Corporate Video